PACB – pacific biosciences of california, inc. (US:NASDAQ)
Stock Stats
News
PacBio to Report First Quarter 2026 Financial Results on May 7, 2026
PacBio and Covaris Announce Joint Workflow Enabling HiFi Long-Read Sequencing of FFPE Tumor Samples
Pacific Biosciences of California (PACB) had its price target lowered by Barclays PLC from $1.50 to $1.00. They now have an "underweight" rating on the stock.
Pacific Biosciences (PACB) Garnering Attention Amid Involvement in Trillion Gene Atlas Program [Yahoo! Finance]
Assembling Over 1,000 Human Genomes Affordably: New Method Powers Medicine's Future [Yahoo! Finance]
Form 4 PACIFIC BIOSCIENCES OF For: Apr 08 Filed by: Gibson Christopher
Form 4 PACIFIC BIOSCIENCES OF For: Apr 01 Filed by: Gibson James R II
Form 144 PACIFIC BIOSCIENCES OF Filed by: Gibson James R II
Form SCHEDULE 13G/A PACIFIC BIOSCIENCES OF Filed by: VANGUARD GROUP INC
Form 8-K PACIFIC BIOSCIENCES OF For: Mar 02
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.